Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2010

01-11-2010 | Review

Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere

Authors: M. E. Falagas, N. V. Cholevas, A. M. Kapaskelis, E. K. Vouloumanou, A. Michalopoulos, P. I. Rafailidis

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2010

Login to get access

Abstract

Preliminary data regarding the experience of countries of the Northern Hemisphere with pandemic 2009 A(H1N1) influenza have already appeared in the literature. We aimed to evaluate the available published literature describing the epidemiological features of pandemic influenza. We searched PubMed; 35 studies (14 referred to European countries, eight to the USA, five to Mexico, four to Canada, two to Japan, one to Colombia, and one reviewed relevant data reported worldwide) were included. Considerably high hospitalization, intensive care unit (ICU) admission, and fatality rates (up to 93.8, 36.4, and 38.5%, respectively) among the evaluated cases were reported across studies with available relevant data. Young and middle-aged adults constituted the majority of the evaluated pandemic cases, with different disease severity (as indicated by the level of care and outcome). Yet, substantial percentages of elderly individuals were reported among more severely afflicted cases. Otherwise healthy patients constituted substantial percentages among evaluated cases with different disease severity. Pregnant women, obese, and morbidly obese patients also constituted substantial percentages of the cases involved in the included studies. The evaluation of the currently available published evidence contributes to the clarification of the epidemiological features of pandemic 2009 A(H1N1) influenza, which is useful in terms of the individual and public health perspectives.
Literature
1.
Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E et al (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25(27):5086–5096CrossRefPubMed
2.
Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J et al (2009) Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med 361(20):1935–1944CrossRefPubMed
3.
Kelly H, Grant K (2009) Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 14(31).
4.
Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R et al (2009) Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 302(17):1896–1902CrossRefPubMed
5.
Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ et al (2009) Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 361(20):1925–1934CrossRefPubMed
6.
Thompson WW, Comanor L, Shay DK (2006) Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis 194(Suppl 2):S82–S91CrossRefPubMed
7.
Rello J, Rodríguez A, Ibañez P, Socias L, Cebrian J, Marques A (2009) Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care 13(5):R148CrossRefPubMed
8.
New influenza A(H1N1) investigation teams (2009) New influenza A(H1N1) virus infections in France, April–May 2009. Euro Surveill 14(21).
9.
Surveillance Group for New Influenza A(H1N1) Virus Investigation and Control in Spain (2009) New influenza A(H1N1) virus infections in Spain, April–May 2009. Euro Surveill 14(19).
10.
Health Protection Agency; Health Protection Scotland; National Public Health Service for Wales; HPA Northern Ireland Swine influenza investigation teams (2009) Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April–June 2009. Euro Surveill 14(22).
11.
Belgian working group on influenza A(H1N1)v (2009) Influenza A(H1N1)v virus infections in Belgium, May–June 2009. Euro Surveill 14(28).
12.
Ciblak MA, Albayrak N, Odabas Y, Basak Altas A, Kanturvardar M, Hasoksuz M et al (2009) Cases of influenza A(H1N1)v reported in Turkey, May–July 2009. Euro Surveill 14(32).
13.
Gilsdorf A, Poggensee G; Working Group Pandemic Influenza A(H1N1)v (2009) Influenza A(H1N1)v in Germany: the first 10,000 cases. Euro Surveill 14(34).
14.
Hahné S, Donker T, Meijer A, Timen A, van Steenbergen J, Osterhaus A et al (2009) Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases. Euro Surveill 14(27).
15.
Cullen G, Martin J, O’Donnell J, Boland M, Canny M, Keane E et al (2009) Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April–3 October 2009. Euro Surveill 14(44).
16.
Lytras T, Theocharopoulos G, Tsiodras S, Mentis A, Panagiotopoulos T, Bonovas S (2009) Enhanced surveillance of influenza A(H1N1)v in Greece during the containment phase. Euro Surveill 14(29).
17.
Yeung JH, Bailey M, Perkins GD, Smith FG (2009) Presentation and management of critically ill patients with influenza A (H1N1): a UK perspective. Crit Care 13(6):426CrossRefPubMed
18.
Lister P, Reynolds F, Parslow R, Chan A, Cooper M, Plunkett A et al (2009) Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet 374(9690):605–607CrossRefPubMed
19.
Smith A, Coles S, Johnson S, Saldana L, Ihekweazu C, O’Moore E (2009) An outbreak of influenza A(H1N1)v in a boarding school in South East England, May–June 2009. Euro Surveill 14(27).
20.
Health Protection Agency West Midlands H1N1v Investigation Team (2009) Preliminary descriptive epidemiology of a large school outbreak of influenza A(H1N1)v in the West Midlands, United Kingdom, May 2009. Euro Surveill 14(27).
21.
Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ et al (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360(25):2605–2615CrossRefPubMed
22.
Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS (2009) H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 374(9688):451–458CrossRefPubMed
23.
Kumar S, Chusid MJ, Willoughby RE, Havens PL, Kehl SC, Ledeboer NA et al (2009) Introduction of a novel swine-origin influenza A (H1N1) virus into Milwaukee, Wisconsin in 2009. Viruses 1(1):72–83CrossRefPubMed
24.
Centers for Disease Control and Prevention (CDC) (2009) Novel influenza A (H1N1) virus infections among health-care personnel—United States, April–May 2009. MMWR Morb Mortal Wkly Rep 58(23):641–645
25.
Saleeby E, Chapman J, Morse J, Bryant A (2009) H1N1 influenza in pregnancy: cause for concern. Obstet Gynecol 114(4):885–891CrossRefPubMed
26.
Crum-Cianflone NF, Blair PJ, Faix D, Arnold J, Echols S, Sherman SS et al (2009) Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries. Clin Infect Dis 49(12):1801–1810CrossRefPubMed
27.
Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J et al (2009) Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302(17):1872–1879CrossRefPubMed
28.
Cutler J, Schleihauf E, Hatchette TF, Billard B, Watson-Creed G, Davidson R et al (2009) Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ 181(3–4):159–163PubMed
29.
O’Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D (2010) Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 182(1):39–44PubMed
30.
Fisman DN, Savage R, Gubbay J, Achonu C, Akwar H, Farrell DJ (2009) Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 361(20):2000–2001CrossRefPubMed
31.
Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A et al (2009) Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 302(17):1880–1887CrossRefPubMed
32.
Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E et al (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361(7):680–689CrossRefPubMed
33.
[No authors listed] (2009) Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 84(21):185–189
34.
Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M et al (2009) Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361(7):674–679CrossRefPubMed
35.
Fajardo-Dolci GE, Hernández-Torres F, Santacruz-Varela J, Rodríguez-Suárez J, Lamy P, Arboleya-Casanova H et al (2009) Epidemiological profile of mortality due to human influenza A (H1N1) in Mexico. Salud Pública Méx 51(5):361–371CrossRefPubMed
36.
Castro-Jiménez MA, Castillo-Pabón JO, Rey-Benito GJ, Pulido-Domínguez PA, Barbosa-Ramírez J, Velandia-Rodriguez DA et al (2009) Epidemiologic analysis of the laboratory-confirmed cases of influenza A(H1N1)v in Colombia. Euro Surveill 14(30):19284PubMed
37.
[No authors listed] (2009) Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009. Wkly Epidemiol Rec 84(24):237–244
38.
Nishiura H, Castillo-Chavez C, Safan M, Chowell G (2009) Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Euro Surveill 14(22).
39.
Vaillant L, La Ruche G, Tarantola A, Barboza P (2009) Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 14(33).
40.
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ et al (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289(2):179–186CrossRefPubMed
41.
Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K (1998) Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 178(1):53–60PubMed
42.
Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J et al (2007) Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 176(4):463–468PubMed
43.
Schanzer DL, Langley JM, Tam TW (2007) Influenza-attributed hospitalization rates among pregnant women in Canada 1994–2000. J Obstet Gynaecol Can 29(8):622–629PubMed
44.
Falagas M, Karamanidou C, Kastoris AC, Karlis G, Rafailidis PI (2009) Psychosocial factors and susceptibility to or outcome of acute respiratory tract infections. Int J Tuberc Lung Dis 14(2):141–148
45.
Falagas ME, Athanasoulia AP, Peppas G, Karageorgopoulos DE (2009) Effect of body mass index on the outcome of infections: a systematic review. Obes Rev 10(3):280–289CrossRefPubMed
46.
47.
Falagas ME, Karageorgopoulos DE (2010) Adjustment of dosing of antimicrobial agents for bodyweight in adults. Lancet 375(9710):248–251CrossRefPubMed
Metadata
Title
Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere
Authors
M. E. Falagas
N. V. Cholevas
A. M. Kapaskelis
E. K. Vouloumanou
A. Michalopoulos
P. I. Rafailidis
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2010
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-1002-3

Other articles of this Issue 11/2010

European Journal of Clinical Microbiology & Infectious Diseases 11/2010 Go to the issue

Letter to the Editor

Carbapenemase-producing Acinetobacter baumannii, Algeria

Brief Report

Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China

Article

Comparative antimicrobial susceptibility of biofilm versus planktonic forms of Salmonella enterica strains isolated from children with gastroenteritis

Article

Phage lysin to supplement phagebiotics to decontaminate processed sputum specimens

Brief Report

Brief report: biomarkers of aortic vascular prosthetic graft infection in a porcine model with Staphylococcus aureus

Article

Use of recombinant chimeric antigens for the serodiagnosis of Mycoplasma pneumoniae infection
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits